Intervention Protocol

Atypical Antipsychotics for Tourette's Syndrome

  1. Anita Pierce1,*,
  2. Hugh E Rickards2

Editorial Group: Cochrane Movement Disorders Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 11 AUG 2009

DOI: 10.1002/14651858.CD008151


How to Cite

Pierce A, Rickards HE. Atypical Antipsychotics for Tourette's Syndrome (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008151. DOI: 10.1002/14651858.CD008151.

Author Information

  1. 1

    Ablett Unit, North Wales NHS Trust, Glan Clwyd Hospital, Home Treatment Team Psychiatry, Bodelwyddan, Denbighshire, UK

  2. 2

    Birmingham and Solihull Mental Health Trust, Neuropsychiatry, Birmingham, West Midlands, UK

*Anita Pierce, Home Treatment Team Psychiatry, Ablett Unit, North Wales NHS Trust, Glan Clwyd Hospital, Sarn Lane, Bodelwyddan, Denbighshire, LL18 5UJ, UK. Anita.pierce@cd-tr.wales.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review will be to evaluate the efficacy and safety of atypical antipsychotics compared with placebo (or no drug) in treating tics in patients with Gilles de la Tourette's syndrome.